PharmaCorp names Andrew Hodson CFO, succeeding Terri Tatchell

PharmaCorp named Andrew Hodson chief financial officer effective Oct. 27, 2026, replacing retiring CFO Terri Tatchell. Tatchell will stay on for three months as a consultant to support the CFO transition. Hodson was head of finance at Marshall Land Systems, overseeing reporting across Canadian and UK entities. He previously served as VP finance at Vendasta Technologies, supporting acquisitions and capital markets work. Earlier, he spent six years at Deloitte Canada leading audit engagements for private and public technology and SaaS companies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmacorp Rx Inc. published the original content used to generate this news brief via (Ref. ID: 202610140730PRIMZONEFULLFEED9845472) on October 14, 2026, and is solely responsible for the information contained therein. (C)